RxDoctor Payments Data
★ My doctorsLook up a doctor →

Piyush Patel

Psychiatry · McDonough, GANPI 1184672008

Payments from drug & device makers

$3,385in general payments, 2019–2025

Across 83 payments — averaging $40.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$908
  • Alkermes, Inc.$333
  • Supernus Pharmaceuticals, Inc.$286
  • E.r. Squibb & Sons, L.L.C.$259
  • AbbVie$218
  • Tris Pharma Inc$192
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,35399%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson15$908
Alkermes, Inc.3$333
Supernus Pharmaceuticals, Inc.11$286
E.r. Squibb & Sons, L.L.C.2$259
AbbVie(2 entities)7$218
Tris Pharma Inc5$192
Neurocrine Biosciences, Inc.2$153
Ironshore Pharmaceuticals Inc.3$137
Neos Therapeutics, LP7$126
Corium, LLC3$119
Noven Pharmaceuticals, Inc.1$114
Axsome Therapeutics, Inc.2$114
Otsuka America Pharmaceutical, Inc.2$90
Shire North American Group Inc4$70
Boehringer Ingelheim3$49
Almatica Pharma LLC2$44
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$35
Takeda Pharmaceuticals U.S.A., Inc.2$34
Ironwood Pharmaceuticals, Inc2$30
Lundbeck LLC2$28
Noven Therapeutics, LLC1$17
Novartis1$16
Gilead1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,385 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate51$3,352
Ziprasidone Hcl19$2,531
Lurasidone Hcl16$1,856
Aripiprazole48$1,508
Duloxetine Hcl40$899
Oxcarbazepine31$839
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine30$750
Divalproex Sodium13$737
Olanzapine36$711
Bupropion XlBupropion Hcl52$507
Buspirone Hcl29$397
Sertraline Hcl73$395
Risperidone38$386
Benztropine Mesylate25$346
Venlafaxine Hcl ErVenlafaxine Hcl31$332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$44$39573 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in McDonough

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →